Recursion Pharmaceuticals, Inc.
NASDAQ:RXRX
5.94 (USD) • At close March 13, 2025
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
| 2024 Q4 | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 Q3 | 2023 Q2 | 2023 Q1 | 2022 Q4 | 2022 Q3 | 2022 Q2 | 2022 Q1 | 2021 Q4 | 2021 Q3 | 2021 Q2 | 2021 Q1 | 2020 Q4 | 2020 Q3 | 2020 Q2 | 2020 Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Activities: | ||||||||||||||||||||
| Net Income
| -178.906 | -95.842 | -97.54 | -91.373 | -92.996 | -93.017 | -76.726 | -65.327 | -57.492 | -60.445 | -65.56 | -55.979 | -64.933 | -47.428 | -43.401 | -30.717 | -25.766 | -23.873 | -18.943 | -18.424 |
| Depreciation & Amortization
| 12.951 | 7.198 | 8 | 7.4 | 15.616 | 7.578 | 5.543 | 3.728 | 3.214 | 2.989 | 2.786 | 2.767 | 2.236 | 2.436 | 2.331 | 1.402 | 1.624 | 0.857 | 1.024 | 0.937 |
| Deferred Income Tax
| 0 | 0 | 0 | 0 | -54.057 | 0.019 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0.827 | 0 | 0 | 0 | 1.757 | 0 | 0 |
| Stock Based Compensation
| 30.784 | 18.253 | 16.524 | 16.127 | 16.086 | 16.792 | 11.811 | 8.814 | 7.695 | 8.907 | 5.675 | 5.632 | 4.341 | 3.363 | 5.317 | 1.821 | 1.188 | 1.07 | 0.769 | 1.265 |
| Change In Working Capital
| 6.048 | 46.715 | -10.264 | -36.451 | -11.27 | -4.462 | -10.121 | -24.404 | -0.601 | -7.765 | -9.537 | 122.824 | -3.959 | 7.29 | -0.275 | -3.362 | 31.554 | 0.28 | 0.617 | -1.617 |
| Accounts Receivables
| -4.828 | 0.304 | 0.736 | -1.04 | -6.422 | -0.203 | -0.814 | -0.317 | 5.572 | 3.777 | -8.086 | -1.265 | -5.376 | 0.016 | 0.013 | 0.085 | 30.043 | -30.19 | 0.06 | 0.082 |
| Change In Inventory
| 0 | 0 | 0 | 0 | -1.334 | 0.203 | 0.814 | 0.317 | -5.572 | -3.777 | 8.086 | 0 | 0 | 6.644 | 2.141 | -2.998 | 4.233 | 0 | 0 | 0 |
| Change In Accounts Payables
| 8.122 | -1.513 | -1.342 | 1.168 | -0.317 | 2.186 | -2.517 | -0.339 | 0.695 | 0.714 | -0.986 | 1.344 | -3.507 | 3.13 | 0.071 | 2.051 | -0.222 | -0.055 | -0.533 | 0.625 |
| Other Working Capital
| 2.754 | 47.924 | -9.658 | -36.579 | -4.531 | -6.648 | -7.604 | -24.065 | -1.296 | -8.479 | -8.551 | 121.48 | -0.452 | -2.5 | -2.5 | -2.5 | -2.5 | 30.525 | 1.09 | -2.324 |
| Other Non Cash Items
| 13.693 | -35.549 | 34.191 | 32.796 | 52.544 | 0.17 | 2.026 | 3.873 | 2.436 | 1.773 | 5.013 | 2.144 | 1.157 | 0.464 | 2.375 | 0.101 | -0.027 | 0.453 | -0.166 | 0.022 |
| Operating Cash Flow
| -115.43 | -59.225 | -82.219 | -102.3 | -74.077 | -72.92 | -67.467 | -73.316 | -44.748 | -54.541 | -61.623 | 77.388 | -61.158 | -33.048 | -33.653 | -30.755 | 8.573 | -19.456 | -16.699 | -17.817 |
| Investing Activities: | ||||||||||||||||||||
| Investments In Property Plant And Equipment
| -1.298 | -1.562 | -4.182 | -6.653 | -2.417 | -0.827 | -3.968 | -5.34 | -7.979 | -8.563 | -16.475 | -4.342 | -4.464 | -9.706 | -6.212 | -19.416 | -4.591 | -0.826 | -0.634 | -0.684 |
| Acquisitions Net
| 277.104 | 0 | 0 | 0 | -0.071 | 0 | 1.915 | 0 | 0 | 0 | 0 | 0 | -184.167 | 0 | 0 | 0 | 0 | -2.6 | 0 | 0 |
| Purchases Of Investments
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -116.97 | -184.167 | 0 | 0 | 0 | 0 | 0 | 0 |
| Sales Maturities Of Investments
| 0 | 0 | 0 | 0 | 0 | 0.48 | 0 | 0 | 0 | 61.547 | 21.415 | 147.646 | 69.191 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Investing Activites
| -0.35 | -3 | -3 | 0 | -0.35 | 0.398 | 0 | -0.165 | -0.3 | 61.247 | 21.415 | 147.646 | 184.167 | -184.167 | 0 | 0 | -0.904 | -2.6 | 0.595 | 0 |
| Investing Cash Flow
| 275.456 | -4.562 | -4.182 | -6.653 | -2.488 | -0.347 | -2.053 | -5.34 | -7.979 | 52.984 | 4.94 | 143.304 | -52.243 | -193.873 | -6.212 | -19.416 | -4.591 | -3.426 | -0.039 | -0.684 |
| Financing Activities: | ||||||||||||||||||||
| Debt Repayment
| -2.101 | -2.287 | -0.026 | -0.026 | -0.694 | -0.024 | -0.024 | -0.024 | -0.023 | -0.023 | -0.022 | -0.022 | -0.021 | -12.737 | -0.02 | -0.02 | -0.02 | -0.02 | 0.382 | 5.981 |
| Common Stock Issued
| 11.03 | 16.968 | 261.546 | 10.873 | 78.093 | 50 | 3.811 | 1.946 | 143.711 | 2.36 | 2.69 | 2.106 | 462.901 | 1.642 | 463.725 | 2.154 | 0 | 0 | 0 | 0 |
| Common Stock Repurchased
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Dividends Paid
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Financing Activities
| 1.71 | 1.781 | 1.602 | 3.05 | 3.26 | 3.789 | 3.811 | 1.946 | 3.568 | 2.36 | 2.69 | 2.106 | 3.817 | 1.642 | 463.725 | 2.154 | 10.055 | 229.741 | 0 | 0.016 |
| Financing Cash Flow
| 10.639 | 16.462 | 263.122 | 13.897 | 80.659 | 53.765 | 3.787 | 1.922 | 147.256 | 2.337 | 2.668 | 2.084 | 3.796 | -11.095 | 463.705 | 2.134 | 10.035 | 229.721 | 0.382 | 5.997 |
| Other Information: | ||||||||||||||||||||
| Effect Of Forex Changes On Cash
| -3.472 | 0.403 | -0.118 | -0.219 | 0.124 | -0.115 | 0.181 | -0.002 | -0.307 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net Change In Cash
| 167.193 | -40.293 | 176.603 | -95.275 | 5.218 | -19.617 | -65.552 | -76.736 | 94.222 | 0.78 | -54.015 | 222.776 | -109.605 | -238.016 | 423.84 | -48.037 | 14.017 | 206.839 | -16.356 | -12.504 |
| Cash At End Of Period
| 603.024 | 435.831 | 476.124 | 299.521 | 394.796 | 397.207 | 416.824 | 482.376 | 559.112 | 464.89 | 464.11 | 518.125 | 295.349 | 404.954 | 642.97 | 219.13 | 267.167 | 253.15 | 46.311 | 62.667 |